MK 287
Alternative Names: L 680573Latest Information Update: 20 Feb 1995
At a glance
- Originator Merck & Co
- Class Antiasthmatics; Anticoagulants; Antiplatelets
- Mechanism of Action Platelet activating factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 20 Feb 1995 Discontinued-II for Asthma in USA (PO)